EMBL Australia

For more than 15 years, EMBL Australia has focused on attracting the very best emerging scientists from across the globe to Australia and delivering top-quality science, as well as state-of-the-art interdisciplinary training to the next generation of researchers. The return on investment is evident.

Looking ahead, sustained long-term investment into international partnerships is essential for Australia to remain at the forefront of health and science research.

In addition to translating discoveries to improve patients’ lives, our group leaders develop transformative tools for the scientific community. One such innovation is a freely available, ultracompact and highly sensitive 3D-printed microscope with the potential to revolutionise health diagnostics.

EMBL Australia group leaders are deeply integrated into Australian and international networks of excellence. They have established themselves as scientists and drive research and innovation in areas of national scientific priority.

In an era of transforming technologies in molecular sequencing, imaging, and artificial intelligence, there is an urgent need for skilled researchers who can bridge the gap between biomedical and computational sciences. Professor Eduardo Eyras is helping address that gap.

Dr Vaishnavi Ananthanarayanan is an innovative cell biologist whose research explores the intricate mechanisms of cellular organisation and a passionate advocate for equity, diversity and inclusion (EDI) in science.

A/Prof Maté Biro (UNSW Sydney) combines his expertise in cellular biology and advanced microscopy to improve cancer treatment efficacy, paving the way for next-generation therapies that could revolutionise the fight against cancer.

A/Prof Mikaël Martino (Monash University) is a renowned innovator in regenerative medicine, known for translating ground-breaking technologies into impactful solutions with the potential to reshape tissue repair and improve patient outcomes.

The long-term support and stability provided to EMBL Australia group leaders enables them to drive transformative advances in Australian research infrastructure, just as Professor David Lynn did.

Dr William Roman is one of the EMBL Australia group leaders pioneering groundbreaking technologies to tackle longstanding scientific challenges.

Dr Senthil Arumugam, an EMBL Australia group leader at the Monash Biomedicine Discovery Institute, is advancing Australia’s scientific infrastructure by developing world-class imaging tools – including a lattice light-sheet microscope with adaptive optics – to deliver exciting new findings.